T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta - Wikidata - awgldk - TriplyDB

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

http://www.wikidata.org/entity/Q33929154

about

Complementary DNA for human glioblastoma-derived T cell suppressor factor, a novel member of the transforming growth factor-beta gene family The latent transforming growth factor beta binding protein (LTBP) family Osteoinductive factor inhibits formation of human osteoclast-like cells The Discovery and Early Days of TGF-β: A Historical Perspective Combining cytotoxic and immune-mediated gene therapy to treat brain tumors Antibody-based immunotherapy for malignant glioma.Experimental approaches for the treatment of malignant gliomas.Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation Transforming growth factor beta inhibits bone resorption in fetal rat long bone cultures.Transforming growth factor beta regulates thyroid growth. Role in the pathogenesis of nontoxic goiter Melanoma-associated expression of transforming growth factor-beta isoforms Tumor-associated transforming growth factor-beta and interleukin-10 contribute to a systemic Th2 immune phenotype in pancreatic carcinoma patients.Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma.Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.Identification of a transforming growth factor beta-1 activator derived from a human gastric cancer cell line.Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors.Immunotherapy of malignant brain tumors.Role of transforming growth factor-beta in the development of the mouse embryo Immunosuppressive mechanisms in glioblastoma.Transactivation of the transforming growth factor beta 1 (TGF-beta 1) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia.Immunoregulatory role of transforming growth factor beta (TGF-beta) in development of killer cells: comparison of active and latent TGF-beta 1 Transforming growth factor-beta: possible roles in carcinogenesis.Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes.TGF-beta: problems and prospects.mRNA coding for neurotransmitter receptors in a human astrocytoma.Mitogenic regulation of normal and malignant breast epithelium.Transforming growth factor-beta2 is a molecular determinant for site-specific melanoma metastasis in the brain Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.Immunotherapeutic approaches for glioma Smad4 is required to inhibit osteoclastogenesis and maintain bone mass.The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients Challenges in clinical design of immunotherapy trials for malignant glioma.Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment.Novel vaccines for glioblastoma: clinical update and perspective.Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.Transforming growth factor beta stimulates the human immunodeficiency virus 1 enhancer and requires NF-kappaB activity.Tumour infiltrating lymphocytes: insights into tumour immunology and potential therapeutic implications.

P2860

Q24298014-9937522F-CF0C-41B2-938E-D00082EA2618 Q24532213-7C71542A-61EC-4F5D-ACEB-EB2ED980ADD8 Q24558710-5207778B-90A9-4C3E-88CB-94EE28F851D1 Q28276556-46B93F34-A2AC-417A-A325-88AF508AF9D9 Q31013320-456328BC-284F-4F86-8A93-21681825E8DD Q34120472-FB572C9F-A2EC-485F-BCAF-6E97538F9C83 Q34127138-04F0F45D-9CC3-43EA-ACB4-87149B17ED87 Q34223630-7A59A1FD-45B5-42C5-9E44-9C8ABC9CC85A Q34560491-35160F5F-A8F8-486F-AE3D-1EF89781A6CF Q34567704-EF52AA00-5A79-49E6-B562-5DF237CD8B5E Q35773976-817640D2-F0E7-45D8-9022-E158F54143B6 Q35787792-F773FF7A-ABA1-4758-BBB2-D7D1A90A44E2 Q35833728-1416858B-8566-49DF-B40D-6F18C0EEEE4D Q35976124-903E4D5F-151B-43E7-A501-DDA6DA3CA6B0 Q35984169-D8B0B3A9-87D2-4398-8F17-D68068911AA5 Q36081157-7D687858-C527-4971-AFAF-9942E7740394 Q36139736-1B9DDFB1-486A-4FD6-94F4-6FDF18E350C1 Q36162929-3842C330-6343-472D-B163-9C6907A4094D Q36217216-455A5D16-E84F-4737-ACBC-2AB1384C1D65 Q36224048-2B5E9F0B-BFE6-46DC-A56D-A0BFE40EF5FA Q36352081-35D084DF-27AA-4B94-800A-467FB05A9D9C Q36354197-284FE2F6-234A-43D0-BF5D-1119491798FB Q36465897-04CCB33B-B36C-4DA1-8426-5D46AF06E827 Q36530354-44F9B00B-7E41-4591-85C8-6E07954E6308 Q36772774-E42BD3D4-7DD2-4923-B380-8ED86CD554DC Q36952481-19D9B20B-A31D-4B84-AE17-7DB4378567DD Q36987868-AF4373A3-A370-4201-AC47-93BB856547F8 Q37078733-1AD0C82E-8639-4B46-98C8-C6EB517B68F6 Q37186248-FBC07849-74A5-4C10-9B5C-66D6D7904A10 Q37267793-B5508AFA-3F41-4EE0-8E50-024573737DCE Q37330422-3AB21442-76C1-47AB-AB4E-E40FE5C9DF61 Q37475929-D748AFBD-B2AD-4A50-8C27-C1FEB5C38E1E Q37640613-334F63D9-25D3-4569-A6E9-4E61599F462D Q37680355-AC9C27AC-EAF2-4C8B-A458-B80E60C18E1E Q37705192-E6288790-D13D-4B62-8557-80821AC8F488 Q37970682-8AE1CCB3-5894-47C7-97A4-3B5314C3F39A Q39043417-F772AD2F-C56C-4989-A927-3D49D150CBCE Q39160992-D41323B7-6CC8-4CAE-A3F5-1B2BC498BF09 Q39631154-EFCFC41C-26F2-473B-86C0-6E258918A27A Q40849487-391B1ED0-0B07-49B0-B676-16B36C4A08F1

P2860

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta

http://www.wikidata.org/entity/Q33929154

description

1987 nî lūn-bûn

@nan

1987 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1987 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1987年の論文

@ja

1987年論文

@yue

1987年論文

@zh-hant

1987年論文

@zh-hk

1987年論文

@zh-mo

1987年論文

@zh-tw

1987年论文

@wuu

name

T cell suppressor factor from ...... ransforming growth factor-beta

@ast

T cell suppressor factor from ...... ransforming growth factor-beta

@en

type

label

T cell suppressor factor from ...... ransforming growth factor-beta

@ast

T cell suppressor factor from ...... ransforming growth factor-beta

@en

prefLabel

T cell suppressor factor from ...... ransforming growth factor-beta

@ast

T cell suppressor factor from ...... ransforming growth factor-beta

@en

P1433

Q33929154-F6DEC935-434E-4108-AA88-C695588BC04F

P1476

Q33929154-05C93A12-43C3-4660-8698-C12FE51D116C

P2093

Q33929154-1837E9E1-9F28-44F1-8651-0D3364BD9254

Q33929154-1B421E7B-948C-4B56-AFE3-AD64D073468E

Q33929154-33B7F23C-EBBB-483C-AEBC-B8D9F586427C

Q33929154-68C1A58D-CB63-4838-85FD-EE632C964199

Q33929154-6B0B97B8-9791-4161-83BD-AFCA64350B1C

Q33929154-812BEFE8-18C4-488D-98BB-35A7E681BB34

Q33929154-A28378D8-12AE-44B1-9163-C2F75D637522

Q33929154-B6E298B7-3CD2-4587-AC2F-DD2B6542B917

P2860

Q33929154-266E2D8A-A1AD-40EC-825F-843E0D8CEFED

Q33929154-291263CB-785A-4DC2-80CB-8D8CFBC661CE

Q33929154-331FF708-1519-4421-95B3-55D35AF97059

Q33929154-5A2D69C6-F906-41A4-8056-0C4A6A2281A1

Q33929154-5EAC3FDE-8BD2-4290-827C-9FD19AD8DCF6

Q33929154-5EB39987-492A-4121-9DBB-8C2C587492B3

Q33929154-602469B4-9B42-44DB-9C35-8C3D739B34D3

Q33929154-613A725D-0B81-4524-A5FF-1338F0C7A11D

Q33929154-69708B76-FC48-4CDA-94CE-B485406A308B

Q33929154-7C1602EF-831D-4FB0-8BC3-E6E8E24CE41A

P304

Q33929154-BDF8D8B2-1A87-4D88-AD42-5A27C7155E6A

P31

Q33929154-3FDA8257-B237-42F6-B1E1-F1730AA5A88A

P407

Q33929154-E7092355-C260-4DC2-AF5D-B1164C855ABB

P433

Q33929154-3F5B5428-07D0-4203-BF3D-DDA410CD154C

P478

Q33929154-B849FF06-5E47-4415-9E9A-797658587217

P577

Q33929154-CD49891C-6E83-4FBC-B0D8-E365E4253434

P698

Q33929154-58C1C6F7-8EDF-4CCF-8302-C139C57166D9

P932

Q33929154-A2B70420-CC34-4F6E-9FF4-4F5EAA69859E

P1433

The EMBO Journal

P1476

T cell suppressor factor from ...... ransforming growth factor-beta

@en

P2093

Bodmer S

http://www.w3.org/2001/XMLSchema#string

Fontana A

http://www.w3.org/2001/XMLSchema#string

Frei K

http://www.w3.org/2001/XMLSchema#string

Hofer E

http://www.w3.org/2001/XMLSchema#string

Hofer-Warbinek R

http://www.w3.org/2001/XMLSchema#string

Siepl C

http://www.w3.org/2001/XMLSchema#string

Wrann M

http://www.w3.org/2001/XMLSchema#string

de Martin R

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

Cleavage of structural proteins during the assembly of the head of bacteriophage T4

Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells

Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.

Ultrasensitive stain for proteins in polyacrylamide gels shows regional variation in cerebrospinal fluid proteins.

Serological analysis of cell surface antigens of malignant human brain tumors

Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.

Purification and characterization of two cartilage-inducing factors from bovine demineralized bone.

Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta.

Letter: Impaired cell-mediated immunity in human brain tumours.

P304

1633-1636

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

1987-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3497030

http://www.w3.org/2001/XMLSchema#string

P932

553535

http://www.w3.org/2001/XMLSchema#string